Marco Pares
Neurological Surgery · Lincoln, NENPI 1003497603
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.5% of the total across 48 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 18.9% — the pattern of someone who eats at a lot of different presentations.
Across 48 payments — averaging $24.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$223
- Novartis$157
- Johnson & Johnson$115
- UCB, Inc.$115
- Amgen$72
- CSL Behring$65
- plus $433 from 15 others
What the payments were for
- Food & beverage$1,09192%
- Education$898%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 11 | $223 |
| Novartis | 8 | $157 |
| Johnson & Johnson | 2 | $115 |
| UCB, Inc. | 3 | $115 |
| Amgen | 2 | $72 |
| CSL Behring | 3 | $65 |
| Pfizer | 2 | $55 |
| Acadia Pharmaceuticals Inc | 2 | $48 |
| Genentech USA, Inc. | 2 | $45 |
| AbbVie | 2 | $38 |
| TG Therapeutics, Inc. | 1 | $37 |
| Springworks Therapeutics, Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Grifols USA, LLC | 1 | $23 |
| Amneal Pharmaceuticals LLC | 1 | $23 |
| EMD Serono, Inc. | 1 | $21 |
| Amicus Therapeutics, Inc. | 1 | $20 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| Argenx US, Inc. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $15 |
How this compares
$1,180 in reported general payments places this provider in the 60th percentile of 49 neurological surgery providers in Nebraska.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pramipexole DihydrochloridePramipexole Di-Hcl | 25 | $402 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Lincoln
- Andrew LivingstonLincoln$44K
- Steven GogelaLincoln$24K
- John HawkinsLincoln$12K
- Jeremy HoseinLincoln$2K
- Benjamin GelberLincoln$1K
- Eric PiersonLincoln$460
- Benjamin BixenmannLincoln$102
- Daniel TomesLincoln$91
- Omar JimenezScottsbluff$33K
- Miki KatzirOmaha$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.